OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!
This video discusses the critical role of the immune system in treating solid tumors, suggesting it's a key breakthrough not widely offered to many a cancer patient. Dr. Dino Prato highlights that the immune system's ability to uniquely target and destroy cancer cells makes it superior to conventional drugs, emphasizing the need for advanced cancer therapy and patient care. We discuss why a precision medicine approach, focusing on immunology, is essential for effective cancer care. 🎯 What You’ll Learn in This Episode • Why the immune system is important in cancer care • What immunotherapy does • Why some tumors evade immune detection • The role of neoantigens and immune signaling • How different immune cells interact • Why responses to immunotherapy vary • The difference between blood cancers and solid tumors • How personalized approaches are being explored 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “The immune system doesn’t just fight cancer — it learns how to find it.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493 [https://www.scirp.org/journal/paperinformation?paperid=132493]
111 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!!